# INDIANA UNIVERSITY INDIANAPOLIS: PROJECT 3: A High Content Clinical Trial of the MEK inhibitor Trametinib in JMML

**Lab Budget Score:** 55/100

| Field | Value |
|---|---|
| Organization | INDIANA UNIVERSITY INDIANAPOLIS |
| Location | INDIANAPOLIS, IN |
| Project | PROJECT 3: A High Content Clinical Trial of the MEK inhibitor Trametinib in JMML |
| Project number | 2U54CA196519-11 |
| Mechanism | U54 |
| Institute | National Cancer Institute |
| Award | $414,395 |
| Awarded | 2026-09-17 |
| Project period | 2015-09-01 to 2031-08-31 |
| UEI | SHHBRBAPSM35 |

## Why this score
- Award of $400K or more.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11422879). Last refreshed: 2026-11-03T18:16:24.961Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.